Form D · Other Technology
CureMint, Inc.
Durham, NC · CIK 0001810766
Offering snapshot reported Mar 6, 2024 · SEC filing
- Reported sold
- $831K Offering amount: $2.5M
- Investors reported
- 5 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Feb 23, 2024 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Mar 6, 2024 | Initial | $831,155 | No comparison | 5 | SEC filing |
| Jan 4, 2023 | Initial | $1,277,257 | No comparison | 9 | SEC filing |
| May 20, 2022 | Initial | $2,199,995 | No comparison | 9 | SEC filing |
| May 20, 2022 | Initial | $550,000 | No comparison | 3 | SEC filing |
| May 13, 2020 | Initial | $1,344,351 | No comparison | 4 | SEC filing |
Offering details
- Securities
- Equity, Other
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-506811
conversion of debt
Source: Form D, filed Mar 6, 2024. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Brandon Mc Carty | Director, Executive |
| Timothy Mc Loughlin | Director |
| Tyson Nargassans | Director, Executive |
Issuer details
Industry: Other Technology (See others in industry)
Address:
201 W. Main Street #310
Durham, NC, 27701
Durham, NC, 27701